BioData Closes Series B Funding Round With Digital Science
Following a Successful Year, Digital Science Continues Its Support of BioData
(firmenpresse) - TEL AVIV, ISRAEL and LONDON -- (Marketwire) -- 07/17/12 -- BioData Ltd., the developer of , the leading research and lab management system, has closed a Series B round of funding with Digital Science, a division of Macmillan Publishers Ltd.
Digital Science's continued support of BioData follows an exceptional year for BioData in which it re-branded and launched Labguru and a new website, released a popular , purchased the assets of LabLife, and integrated from Sigma Life Science and Nature Protocols into Labguru. In addition BioData signed a site license agreement with the Technion's Rappaport Institute. The company enjoys a growing user base of over 40,000 researchers.
"BioData and Digital Science exist at a time when scientists are changing long-established habits and increasingly adopting digital productivity tools out of necessity to remain competitive. This is an exciting time for all of the BioData team. We enjoy support from Digital Science along with an ongoing dialog with top researchers worldwide -- ensuring we develop the lab management tools a research group needs in order to do great science," said , Founder and Co-CEO of BioData. "We have invested a lot this year in rebranding and revamping the product, building a winning team, and developing tools to better serve our growing user base."
BioData is among Digital Science's portfolio companies, which also includes SureChem, Labtiva, 1DegreeBio, Bioraft and Symplectic. Together they support Digital Science's mandate to provide cutting edge software and technology to make scientific research more efficient.
"BioData has had a tremendous year. is proving to be a powerful and distinctive product, and customer feedback has been excellent. It really is changing the way that researchers work," said Timo Hannay, Managing Director, Digital Science. "We are delighted to have BioData as part of our portfolio, and look forward to even greater success in the year to come."
In the coming year BioData plans to offer additional features for accessing third-party , products and materials databases so that Labguru users may improve how they plan experiments and manage inventory and orders.
Based in Boston and Tel Aviv, BioData Ltd. creates digital tools for increasing the productivity of academic and industrial laboratories. BioData's web-based software is currently used by thousands of researchers in hundreds of labs worldwide. For more information, visit
Digital Science is a division of Macmillan Publishers Ltd., launched in December 2010 to provide technology solutions for researchers. From intelligent knowledge discovery tools to software applications for the laboratory and decision-support systems for managers, Digital Science combines world-class technology with a resolute focus on scientists and those who support the research process. For more information, visit
Michal Frenkiel
VP, Marketing
+ (972) 52-620 - 1111
Alan Zachary, Ph.D.
+ (1) 312-506-5220
Ryan Ferrell
+ (1) 312-506-5202
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 17.07.2012 - 06:00 Uhr
Sprache: Deutsch
News-ID 1133589
Anzahl Zeichen: 0
contact information:
Contact person:
Town:
TEL AVIV, ISRAEL and LONDON
Phone:
Kategorie:
Equipment & Supplies
Anmerkungen:
Diese Pressemitteilung wurde bisher 173 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"BioData Closes Series B Funding Round With Digital Science
"
steht unter der journalistisch-redaktionellen Verantwortung von
BioData, Ltd. (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
